Ulm, Germany

Annette Schuler-Metz

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: Annette Schuler-Metz: Innovator in Medicinal Chemistry

Introduction

Annette Schuler-Metz, located in Ulm, Germany, is a prominent inventor known for her significant contributions to the field of medicinal chemistry. With an impressive portfolio of 31 patents, her work has advanced the development of various pharmaceutical compounds, notably in the realm of glycinamides.

Latest Patents

One of Annette's latest patents revolves around substituted glycinamides, detailing a process for their manufacture and use as medicaments. This invention introduces a novel class of substituted glycinamides characterized by a general formula, highlighting tautomers, enantiomers, diastereomers, and their mixtures. The modifications made in these compounds result in physiologically acceptable salts that boast valuable therapeutic properties.

Career Highlights

Throughout her career, Annette Schuler-Metz has been associated with leading pharmaceutical companies, notably Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. Her tenure at these organizations has provided her with the platform to innovate and integrate her research into commercially viable medications. Her dedication to the development of new treatments has been a driving force in her professional journey.

Collaborations

Annette's innovative spirit is complemented by her collaborations with esteemed colleagues in the field. Among her coworkers are Henning Priepke and Herbert Nar, both of whom have played crucial roles in advancing their shared research initiatives and contributing to groundbreaking developments in medicinal chemistry.

Conclusion

With her extensive experience and a remarkable track record in patenting innovative solutions, Annette Schuler-Metz continues to be a pivotal figure in the pharmaceutical industry. Her contributions not only enhance the understanding of glycinamides but also hold the potential to improve patient care by introducing new therapeutic alternatives. As she forges ahead in her career, her inventions will undoubtedly leave a lasting impact on the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…